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The malignant early repolarization (ER) and Brugada
syndromes (BS) are viewed as separate disorders sharing
pathophysiological characteristics (1,2). Having said that,
a clear “détente” between the 2 has prevailed: J waves,
particularly when followed by a horizontal ST-segment (3),
are the hallmark of ER, although only when present in the
inferior and/or lateral leads (4). By contrast, only the pres-
ence of coved “type-I” ST-segment elevation is considered
diagnostic of BS and only when present in the right pre-
cordial (V1 to V3) leads (5). Speciﬁcally, to launch the
malignant ER as a novel form of idiopathic ventricular
ﬁbrillation (VF) not to be confused with BS, Haissaguerre
et al. (6) scrutinized the inferior, lateral, and anterolateral
leads for the presence of J waves while intentionally avoid-
ing the right precordial leads. Every subsequent study
conﬁrming the association of J waves with idiopathic VF
(4) adopted the same approach, deliberately neglecting
leads V1 to V3.
See page 1610
In this issue of the Journal, Kamakura et al. (7) take a fresh
look at ER by reporting on the signiﬁcance of J waves in V1
to V3, literally “trespassing into Brugada territory.” They
studied 84 patients with idiopathic VF, including 40 with
BS, 13 with idiopathic VF with normal electrocardiogram
(ECG), and 31 with ER (7). The last group was subdivided
into 2: 19 patients had “classic early repolarization” with J
waves restricted to the inferolateral leads, whereas the
remaining 12 had J waves both in the inferolateral and the
right precordial leads (7). This latter group, with “early
repolarization in Brugada territory,” represents a new cate-
gory of patients, hitherto ignored. Because none of them
developed a type I Brugada pattern when challenged with
a sodium channel blocker (7), patients with ER in Brugada
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cordial repolarization (either in the form of right precordial
ER or with frank type I Brugada pattern) shared important
characteristics: spontaneous VF predominantly during sleep;
and high risk for spontaneous VF recurrence (7).
This is not the ﬁrst challenge to the credence maintaining
that the type I Brugada ECG is the only right precordial risk
indicator for cardiac arrest. A previous Japanese study (8)
showed that the risk for spontaneous VF among patients
with type II or type III Brugada pattern (also termed “non-
type I Brugada pattern”) was similar to that of patients with
coved type I. Of note, 8% of the patients with non-type I
Brugada pattern in that study (8) also had J waves in the
inferolateral leads, and for those patients, the VF risk was
twice as high. Thus, whether patients with inferolateral ER
are noted to have right precordial J waves (as in the present
study) (7) or whether patients with “non-type I Brugada are
noted to have inferolateral J waves” (as in the aforemen-
tioned study) (8), having J waves in 2 territories portends
a higher risk.
And the plot thickens: Rollin et al. (9) recently reported
that 9% of patients with classic BS also have type I, coved
ST-segment elevation, in at least 1 limb lead. Here, too,
having a type I Brugada pattern in 2 territories was
associated with a 5-fold increase in the risk for sponta-
neous VF (9). As discussed elsewhere (10), the emerging
picture is that a greater “Brugada burden,” manifesting as
a type I Brugada pattern that is more severe (with higher
ST-segment elevation), more frequent (observed in more
ECGs recorded over time), or more widespread (observed in
more leads), is a marker of higher risk.
As more and more variant ECG abnormalities are
recognized to be associated with a higher arrhythmic-risk,
the naive reader might conclude that almost everybody has
some form of ECG abnormality and that these individuals
are about to drop dead! An exaggeration?Well.consider the
following. First, QTc values as short as 440 ms might be seen
in patients with genetically conﬁrmed long QT syndrome,
whereas at least 1 patient with well-characterized short QT
syndrome has had a QTc interval as long as 432 ms (11).
Because these values, reﬂecting “short” or “long,” represent
the 60th and the 80th percentiles of the QTc interval in the
healthy population (12), the inevitable conclusion is that
only 20% of healthy individuals have unequivocally normal
QT. Second, in population-based studies, as many as 9% of
unselected adults have the “malignant form of early repo-
larization” (J waves with horizontal ST-segment), and these
individuals are at increased risk of dying suddenly (3). Third,
although the type I Brugada ECG is found in only 1 in 2,000
individuals (13), our data suggest that this pattern will be
identiﬁed 20 times more frequently if only the ECG
screening is performed at the time of fever (14). We must
now add to these intimidating numbers the entity of “right-
precordial J waves not meeting Brugada syndrome criteria yet
associated with VF,” as described here by Kamakura et al. (7).
Although Kamakura did not include a control group (7),
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type II to III Brugada pattern (13), and many more will have
some form of J-point elevation in the right precordial leads.
Individuals with a perfect ECG might soon prove hard to
ﬁnd, by these accounts.
The concept of “J waves in Brugada territory” has impor-
tant implications. Electrophysiologists are already being
consulted about the risk for arrhythmic death in young
individuals who are asymptomatic but have prominent J
waves. This “fear of J waves” (2) is likely to worsen once we
start counting J waves in the right precordial leads. To keep
matters in the proper perspective, it is important to re-
member the following points. First, the study by Kamakura
et al. (7) included only VF survivors; the heightened risk of
patients with J waves in 2 territories should not be extrapo-
lated to asymptomatic individuals, who invariably have
better prognosis. In the previous Japanese study (8) that did
include asymptomatic individuals, long-term risk was driven
primarily by the presence of symptoms: none of the initially
asymptomatic individuals with non-type I Brugada pattern
developed arrhythmias during a 4-year follow-up, regard-
less of the number of leads reﬂecting this phenomenon (8).
Second, in the Rollin study (9), the risk for developing VF
among asymptomatic individuals with type I Brugada in 2
lead territories reached 13% at 5 years, but this event rate
requires conﬁrmation, because it was based on only 2 cases.
Third, the risk of idiopathic VF among asymptomatic indi-
viduals with “malignant early repolarization” (3) is estimated
at only 1 in 3,000. Although high in relative terms (i.e., in
comparison with the general population), the risk is low in
absolute terms. Thus, the message that we ought to be
delivering must be calming. Things are not as bad as they
might seem for the asymptomatic individual with J waves.
Finally, the concept of “J waves in Brugada territory” also
has important implications for individuals in need of medi-
cations that block the cardiac sodium channel (15). Asymp-
tomatic individuals who have non-type I ST-segment
elevation in V1 to V3 have an excellent long-term prognosis
even if their ECG pattern converts to type I when challenged
with a sodium channel blocker, even if they also have
inducible VF during electrophysiological studies (16). The
caveat to this reassuring statement is that individuals with
drug-induced type I Brugada ECG will do well in the
absence of drugs. Common sense dictates that such patients
should vigilantly avoid treatment with any sodium channel
blocker. Accumulating data suggest that the drug-induced
Brugada syndrome is as important as the better-known
drug-induced long QT syndrome (17). Interestingly, patients
who developed drug-induced torsade de pointes might be
identiﬁed through a drug challenge with a potassium channel
blocker (18). Whether individuals with J waves should
undergo a drug challenge with a sodium channel blockertomake sure theydonotdevelop a type IBrugadapattern, before
they receive potentially Brugadogenic medications (such as
antipsychotic medications) for long-term use, is a thought that
needs to be considered.
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